These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 35219646)
41. Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. Ota I; Masui T; Kurihara M; Yook JI; Mikami S; Kimura T; Shimada K; Konishi N; Yane K; Yamanaka T; Kitahara T Oncol Rep; 2016 Jan; 35(1):261-6. PubMed ID: 26498709 [TBL] [Abstract][Full Text] [Related]
42. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen, Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491 [No Abstract] [Full Text] [Related]
43. SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival. Schinke H; Pan M; Akyol M; Zhou J; Shi E; Kranz G; Libl D; Quadt T; Simon F; Canis M; Baumeister P; Gires O Mol Oncol; 2022 Jan; 16(2):347-367. PubMed ID: 34382739 [TBL] [Abstract][Full Text] [Related]
44. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer. Lee HK; Lee DS; Park JC BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941 [TBL] [Abstract][Full Text] [Related]
45. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures. Essid N; Chambard JC; Elgaaïed AB Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250 [TBL] [Abstract][Full Text] [Related]
46. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway. Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902 [TBL] [Abstract][Full Text] [Related]
47. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma. Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389 [TBL] [Abstract][Full Text] [Related]
48. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
49. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892 [TBL] [Abstract][Full Text] [Related]
50. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma. Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907 [TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605 [TBL] [Abstract][Full Text] [Related]
52. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
53. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma. Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213 [TBL] [Abstract][Full Text] [Related]
54. Changes of immune microenvironment in head and neck squamous cell carcinoma in 3D-4-culture compared to 2D-4-culture. Xiao J; Song Y; Gao R; You M; Deng C; Tan G; Li W J Transl Med; 2023 Oct; 21(1):771. PubMed ID: 37907991 [TBL] [Abstract][Full Text] [Related]
55. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228 [TBL] [Abstract][Full Text] [Related]
56. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma. Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546 [TBL] [Abstract][Full Text] [Related]
57. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma. Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells. Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032 [TBL] [Abstract][Full Text] [Related]
59. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306 [TBL] [Abstract][Full Text] [Related]
60. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]